Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (22)
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani & Renzo M Lombardo. (2022) Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation. World Journal of Cardiology 14:11, pages 576-598.
Crossref
Crossref
Francesco De Stefano, Alberto Benassi, Alberto Maria Cappelletti, Francesco Donatelli, Damiano Regazzoli, Salvatore Tolaro, Francesca Perego, Angelo Silverio, Alessandra Scatteia, Pasquale Guarini, Santo Dellegrottaglie, Simona Mariani, Elpidio Pezzella, Gennaro Galasso & Francesco Caiazza. (2022) Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study. Journal of Personalized Medicine 12:9, pages 1419.
Crossref
Crossref
Clara Bonanad, Francisca Esteve-Claramunt, Sergio García-Blas, Ana Ayesta, Pablo Díez-Villanueva, Jose-Ángel Pérez-Rivera, José Luis Ferreiro, Joaquim Cánoves, Francisco López-Fornás, Albert Ariza Solé, Sergio Raposerias, David Vivas, Regina Blanco, Daznia Bompart Berroterán, Alberto Cordero, Julio Núñez, Lorenzo Fácila, Iván J. Núñez-Gil, José Luis Górriz, Vicente Bodí, Manuel Martínez-Selles, Juan Miguel Ruiz Nodar & Francisco Javier Chorro. (2022) Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes. Journal of Clinical Medicine 11:11, pages 3008.
Crossref
Crossref
Marco Proietti, Marina Camera, Maurizio Gallieni, Luigi Gianturco, Antonio Gidaro, Carlo Piemontese, Giuseppe Pizzetti, Franco Redaelli, Barbara Scimeca, Carlo Sebastiano Tadeo, Matteo Cesari, Giuseppe Bellelli & Laura Adelaide Dalla Vecchia. (2022) Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document. Journal of Personalized Medicine 12:3, pages 469.
Crossref
Crossref
Zhiyan Liu, Lingyue Ma, Hanxu Zhang, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zining Wang, Zhe Wang, Kun Hu, Yanjun Gong, Jie Jiang, Qian Xiang & Yimin Cui. (2021) Comparison of non‐vitamin K antagonist oral anticoagulants on bleeding and thrombosis. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1729-1742.
Crossref
Crossref
Muhammad Yasir Tarar, Xin Yin Choo & Shoaib Khan. (2021) The Risk of Bleeding Complications in Intra-Articular Injections and Arthrocentesis in Patients on Novel Oral Anticoagulants: A Systematic Review. Cureus.
Crossref
Crossref
Niklas Wallvik, Henrik Renlund & Anders Själander. (2020) Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants. Journal of Thrombosis and Thrombolysis 52:1, pages 315-323.
Crossref
Crossref
Joris R de Groot, Thomas W Weiss, Peter Kelly, Pedro Monteiro, Jean Claude Deharo, Carlo de Asmundis, Esteban López-de-Sá, Johannes Waltenberger, Jan Steffel, Pierre Levy, Ameet Bakhai, Wolfgang Zierhut, Petra Laeis, Marius Constantin Manu, Paul-Egbert Reimitz, Raffaele De Caterina & Paulus Kirchhof. (2021) Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study. European Heart Journal - Cardiovascular Pharmacotherapy 7:FI1, pages f30-f39.
Crossref
Crossref
Giuseppe Patti & Sylvia Haas. (2021) Non–Vitamin K Antagonist Oral Anticoagulants and Factors Influencing the Ischemic and Bleeding Risk in Elderly Patients With Atrial Fibrillation: A Review of Current Evidence. Journal of Cardiovascular Pharmacology 77:1, pages 11-21.
Crossref
Crossref
C. Hoffmann, C. Leven, R. Le Mao, C. De Moreuil & K. Lacut. (2020) Anticoagulants oraux directs : dans quelles indications ? Lequel prescrire ? Pour ou contre chez les personnes fragiles et dans les situations atypiques ? Quelle surveillance et gestion des accidents hémorragiques ?. La Revue de Médecine Interne 41:9, pages 598-606.
Crossref
Crossref
Martín Ruiz Ortiz, Javier Muñiz, María Asunción Esteve-Pastor, Francisco Marín, Inmaculada Roldán, Angel Cequier, Manuel Martínez-Sellés, Hugo González Saldivar, Vicente Bertomeu & Manuel Anguita. (2020) Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study. Journal of Cardiovascular Pharmacology and Therapeutics 25:4, pages 316-323.
Crossref
Crossref
Farhad Pazan, Ronan Collins, Victor M. Gil, Olivier Hanon, Roland Hardt, Martin Hoffmeister, Pedro Monteiro, Terence J. Quinn, Dieter Ropers, Giuseppe Sergi, Freek W. A. Verheugt & Martin Wehling. (2020) A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019). Drugs & Aging 37:7, pages 539-548.
Crossref
Crossref
Nanbo Zheng, Xiaonian Han, Lirong Peng, Xiaojing Nie, Jinping Wang, Li Ma & Xin Zan. (2020) Assessment of direct oral anticoagulants administered as potentially inappropriate medications to elderly inpatients. International Journal of Clinical Pharmacy 42:3, pages 871-878.
Crossref
Crossref
Carmen Suárez Fernández, Alejandra Gullón & Francesc Formiga. (2020) The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation. Journal of Comparative Effectiveness Research 9:7, pages 509-523.
Crossref
Crossref
Petra Šinigoj, Nina Vene, Katarina Košmelj & Alenka Mavri. (2020) Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience. International Journal of Clinical Pharmacy 42:2, pages 445-452.
Crossref
Crossref
Mareva Faure, Anne‐Marie Castilloux, Agnès Lillo‐Le‐Louet, Bernard Bégaud & Yola Moride. (2019) Secondary Stroke Prevention: A Population‐Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or Recurrence. Clinical Pharmacology & Therapeutics 107:2, pages 443-451.
Crossref
Crossref
Magali P. A. Disdier Moulder, Abby K. Hendricks & Narith N. Ou. (2019) Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?. Clinical Cardiology 43:2, pages 137-144.
Crossref
Crossref
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov & V. V. Fomin. (2020) Laboratory bleeding predictors in elderly patients with atrial fibrillation taking direct oral anticoagulants. Medical Council:21, pages 40-43.
Crossref
Crossref
M. A. GabitovaP. M. KrupeninA. A. SokolovaD. A. NapalkovV. V. Fomin. (2020) Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation. Rational Pharmacotherapy in Cardiology 15:6, pages 802-805.
Crossref
Crossref
Antoni Riera-Mestre, Miguel Camafort, Jose María Suriñach, Francisco José Muñoz Rodríguez, Ferran Padilla, Jaume Francisco-Pascual, José Mateo Arranz, Antonio Martínez Rubio, Roger Villuendas Sabaté, Román Freixa-Pamias, Carmen Suárez Fernández & Amparo Santamaría. (2020) Anticoagulación del paciente anciano pluripatológico con fibrilación auricular no valvular: papel del rivaroxabán. Revista Española de Cardiología Suplementos 20, pages 3-10.
Crossref
Crossref
Masaya Shinohara, Ryou Wada, Shintaro Yao, Kensuke Yano, Katsuya Akitsu, Hideki Koike, Toshio Kinoshita, Hitomi Yuzawa, Takeya Suzuki, Tadashi Fujino & Takanori Ikeda. (2019) Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty. Journal of Arrhythmia 35:6, pages 795-803.
Crossref
Crossref
D. A. NapalkovA. A. Sokolova. (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy. Rational Pharmacotherapy in Cardiology 15:4, pages 553-557.
Crossref
Crossref